Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study.

Phillips, Emma C; Warren, Cirle A; Ma, Jennie Z; Madden, Gregory R

Phillips, Emma C; Warren, Cirle A; Ma, Jennie Z; Madden, Gregory R.

Afiliação

Phillips EC; University of Virginiagrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.
Warren CA; Division of Infectious Diseases & International Health, Department of Medicine, University of Virginiagrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.
Ma JZ; Department of Public Health Sciences, University of Virginiagrid.27755.32 Health System, Charlottesville, Virginia, USA.
Madden GR; Division of Infectious Diseases & International Health, Department of Medicine, University of Virginiagrid.27755.32 School of Medicine, Charlottesville, Virginia, USA.

Antimicrob Agents Chemother ; 66(6): e0000122, 2022 06 21.

Article em En | MEDLINE | ID: mdl-35647645

Assuntos

Clostridioides difficile; Infecções por Clostridium; Tigeciclina; Antibacterianos/uso terapêutico; Infecções por Clostridium/tratamento farmacológico; Humanos; Estudos Retrospectivos; Tigeciclina/uso terapêutico

Palavras-chave

Clostridioides difficile; tigecycline

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google